Ergotamine Disease Interactions
There are 2 disease interactions with ergotamine.
Amine ergots (applies to ergotamine) cardiovascular adverse effects
Major Potential Hazard, Moderate plausibility. Applicable conditions: Tachyarrhythmia
The amine ergot alkaloids, ergonovine and methylergonovine, can cause serious cardiovascular complications because of their vasospastic effects. Hypertension (more often with ergonovine) has been most commonly reported, particularly when administered IV undiluted or at an excessive rate or when used in conjunction with regional anesthesia or vasoconstrictors. Headaches, seizures, cerebrovascular accidents and death have been associated with the hypertensive episodes. Other, less common adverse effects include acute myocardial infarction, transient chest pains, thrombophlebitis, tachycardia and palpitations. Therapy with ergot alkaloids should generally be avoided, except under special circumstances, in patients with chronic hypertension, preeclampsia or eclampsia, cardiovascular disease, cerebrovascular disease, or peripheral vascular disease. Caution is advised when these agents are administered to patients with venoatrial shunts, mitral valve stenosis, or sepsis. Close monitoring of cardiovascular status is highly recommended during therapy.
- American Medical Association, Division of Drugs and Toxicology "Drug evaluations annual 1994." Chicago, IL: American Medical Association; (1994):
- "Product Information. Ergotrate Maleate (ergonovine)." Bedford Laboratories (2001):
- "Product Information. Methergine (methylergonovine)." Novartis Pharmaceuticals (2010):
Ergot alkaloids (applies to ergotamine) vasospastic reactions
Major Potential Hazard, High plausibility. Applicable conditions: Liver Disease, Peripheral Arterial Disease, Shock, Renal Dysfunction, Sepsis, Ischemic Heart Disease, Hypertension
The use of ergot alkaloids is contraindicated in patients with conditions predisposing them to vasospastic reactions, including, ischemic heart disease (angina, history of myocardial infarction, silent ischemia), peripheral vascular disease, sepsis, shock, vascular surgery, uncontrolled hypertension, and severely impaired hepatic or renal function. The vasoconstriction produced be ergot alkaloids may exacerbate these conditions. Ergot alkaloids may cause vasospastic reactions other than coronary artery vasospasm such as peripheral vascular reactions, and colonic ischemia, causing muscle pains, numbness, coldness, pallor, and cyanosis of the digits. In patients with compromised circulation, persistent vasospasm may result in gangrene or death. Nitroprusside and heparin have been used to treat ergotamine- induced severe vasoconstriction.
- "Product Information. D.H.E. 45 (dihydroergotamine)." Sandoz Pharmaceuticals Corporation (2002):
- "Product Information. Migranal (dihydroergotamine nasal)." Novartis Pharmaceuticals (2001):
Ergotamine drug interactions
There are 304 drug interactions with ergotamine.
Ergotamine alcohol/food interactions
There are 3 alcohol/food interactions with ergotamine.
More about ergotamine
- ergotamine consumer information
- Check interactions
- Reviews (4)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antimigraine agents
- En español
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.